| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968789 | Vaccine | 2011 | 12 Pages |
Abstract
⺠A phase I/II HIV vaccine trial has been conducted in Tanzania employing priming with HIV-1 DNA and boosting HIV-1 MVA. ⺠It has demonstrated excellent safety and immunogenicity by eliciting cell-mediated as well as antibody responses to Env. ⺠The superiority of low dose intradermal over high dose intramuscular HIV-DNA vaccination has been found. ⺠The capacity built paves the way for further HIV vaccine trials in Tanzania by collaboration between the North and South.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Muhammad Bakari, Said Aboud, Charlotta Nilsson, Joel Francis, Deus Buma, Candida Moshiro, Eric A. Aris, Eligius F. Lyamuya, Mohamed Janabi, Karina Godoy-Ramirez, Agricola Joachim, Victoria R. Polonis, Andreas Bråve, Patricia Earl, Merlin Robb,